Stockscreener 앱 받기
0.682
2.57%
-0.018
시간 외 거래:
.68
-0.002
-0.29%
전일 마감가:
$0.70
열려 있는:
$0.67
하루 거래량:
92,323
Relative Volume:
0.02
시가총액:
$5.08M
수익:
-
순이익/손실:
$-16.28M
주가수익비율:
-0.049
EPS:
-13.91
순현금흐름:
$-13.75M
1주 성능:
-2.32%
1개월 성능:
-5.41%
6개월 성능:
-64.29%
1년 성능:
-85.94%
1일 변동 폭
$0.65
$0.72
1주일 범위
$0.65
$0.73
52주 변동 폭
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
명칭
Pasithea Therapeutics Corp
전화
(702) 514-4174
주소
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
KTTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.682 | 5.10M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp 주식(KTTA)의 최신 뉴스
Combining machine learning predictions for Pasithea Therapeutics Corp.Entry and Exit Strategy for Swing Traders - Newser
Visual trend scoring systems applied to Pasithea Therapeutics Corp. Equity WarrantFree Early Entry Tips With Low Risk Zone - Newser
Visualizing Pasithea Therapeutics Corp. Equity Warrant stock with heatmapsMarket Opportunity Tracker for Swing Traders - Newser
Sentiment analysis tools applied to Pasithea Therapeutics Corp.Free Technical Stock Breakout Predictions - Newser
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp.ROI Focused Setup With Drawdown Analysis - Newser
Published on: 2025-08-09 23:27:53 - Newser
Will Pasithea Therapeutics Corp. Equity Warrant price bounce be sustainableMonthly Trade Result and Signal Summary - Newser
Is a relief rally coming for Pasithea Therapeutics Corp. holdersDay Trading Plan with Entry Risk Management - Newser
How Pasithea Therapeutics Corp. Equity Warrant stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Pasithea Therapeutics Corp. Equity Warrant stock momentum explainedTen-Year Sector Performance and Summary Analysis - Newser
Exit strategy if you’re trapped in Pasithea Therapeutics Corp. Equity WarrantShort-Term AI-Based Stock Price Forecast - Newser
Published on: 2025-08-09 05:58:34 - Newser
Real time pattern detection on Pasithea Therapeutics Corp. stockVolume Confirmed Setup with Entry Confidence - Newser
How to read the order book for Pasithea Therapeutics Corp. Equity WarrantEntry Zone Forecast for Momentum Trading - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from interest rate changesEntry Opportunity Screener with Confirmation - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. strategies - Newser
Long term hold vs stop loss in Pasithea Therapeutics Corp.Free Triple Return Setup with Risk Control - Newser
Pasithea Therapeutics Corp. Equity Warrant stock trendline breakdownFree AI Driven Buy Alert Trade Blueprint - Newser
Does Pasithea Therapeutics Corp. Equity Warrant fit your quant trading modelBuy Strategy Review With Performance Summary - Newser
Using AI based signals to follow Pasithea Therapeutics Corp. Equity WarrantFree Target Return Focused Trade Insights - Newser
Certain Common Stock of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 6-AUG-2025. - MarketScreener
Real Time Chart Alerts Flash Bullish on Pasithea Therapeutics Corp.Trade Setups With AI Powered Filters Published - beatles.ru
What institutional investors are buying Pasithea Therapeutics Corp. Equity Warrant stockGet exclusive access to expert stock recommendations - Jammu Links News
How does Pasithea Therapeutics Corp. Equity Warrant generate profit in a changing economyCapitalize on emerging market opportunities - Jammu Links News
What is the risk reward ratio of investing in Pasithea Therapeutics Corp. stockMaximize your portfolio’s growth with expert tips - Jammu Links News
What analysts say about Pasithea Therapeutics Corp. stockMaximize gains with data-driven trading alerts - Jammu Links News
What makes Pasithea Therapeutics Corp. stock price move sharplySuperior profit margins - Jammu Links News
What catalysts could drive Pasithea Therapeutics Corp. stock higher in 2025Capitalize on proven investment strategies - Jammu Links News
Is Pasithea Therapeutics Corp. Equity Warrant a growth stock or a value stockAchieve breakthrough profits with smart strategies - Jammu Links News
Does Pasithea Therapeutics Corp. stock perform well during market downturnsAchieve breakthrough profits with expert advice - Jammu Links News
What analysts say about Pasithea Therapeutics Corp. Equity Warrant stockBreakthrough stock performance - Jammu Links News
What drives Pasithea Therapeutics Corp. Equity Warrant stock priceCapitalize on fast-growing stocks today - Jammu Links News
Pasithea Therapeutics Corp. Equity Warrant Stock Analysis and ForecastBuild a winning investment portfolio - Jammu Links News
When is Pasithea Therapeutics Corp. Equity Warrant stock expected to show significant growthUnmatched market gains - Jammu Links News
Is it the right time to buy Pasithea Therapeutics Corp. stockFree Trend-Following Techniques - Jammu Links News
Does Pasithea Therapeutics Corp. Equity Warrant stock perform well during market downturnsFree Predictions - Jammu Links News
Why is Pasithea Therapeutics Corp. Equity Warrant stock attracting strong analyst attentionBuild wealth faster with expert stock selection - Jammu Links News
What is Pasithea Therapeutics Corp. Equity Warrant company’s growth strategyDiscover hidden gems in the stock market - Jammu Links News
How strong is Pasithea Therapeutics Corp. Equity Warrant company’s balance sheetRapid capital growth - Jammu Links News
Should I hold or sell Pasithea Therapeutics Corp. stock in 2025Financial News Planner For Beginners - Jammu Links News
Price action breakdown for Pasithea Therapeutics Corp. Equity WarrantWeekly Chart-Based Forecast for Traders - Newser
Why Pasithea Therapeutics Corp. stock attracts strong analyst attentionSwing Trade Watchlist with Entry Zones - Newser
Can machine learning forecast Pasithea Therapeutics Corp. recoveryReal-Time Signal Tracking with Entry Level - Newser
Pasithea Therapeutics Corp (KTTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):